Close Menu

MALDI mass spectrometry

The firm's diagnostics and genomics group saw an 11 percent year-over-year revenue increase in the third quarter.

Under the agreement, MRM Proteomics has granted Biodesix rights to use its iMALDI mass spectrometry technologies to develop blood-based tests for lung cancer.

The new version of the mass spectrometry-based system adds 144 microbial species to its database and includes new tools for sample preparation.

With the exception of Thermo Fisher Scientific, which released three new instruments, vendors focused mainly on expanded applications of existing platforms.

The firms will work to implement MALDI PharmaPulse high-throughput mass spec instrumentation at AMRI's Integrated Drug Discovery Center.

Certain alleles at two SNP sites in TP53 coincided with decreased colorectal cancer risk or an earlier time of disease onset in a study of almost 300 Taiwanese individuals with Lynch syndrome.

The mass spectrometry services and instrument firm is working with a Yale pathologist to develop proteomic tests for solid tumors.

Unlike MALDI-based microbial ID efforts from companies like Bruker and BioMérieux, the SimulTOF effort is focused not on clinical work but rather research uses.

Conference attendees discussed the growing number of MALDI-TOF applications while recognizing that LDT regulation poses a particular threat to mass spec-based tests.

NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded Labcyte $1 million to create a process for detecting cancer-associated proteins in samples, the company announced today.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.